These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8707747)

  • 21. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of azithromycin against Chlamydia trachomatis.
    Scieux C; Bianchi A; Chappey B; Vassias I; Pérol Y
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():7-10. PubMed ID: 2154440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa.
    Yee YC; Kisslinger B; Yu VL; Jin DJ
    J Antimicrob Chemother; 1996 Jul; 38(1):133-7. PubMed ID: 8858465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination.
    Christensen JJ; Holten-Andersen W; Nielsen PB
    Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):329-32. PubMed ID: 3788573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
    Cevenini R; Sambri V; La Placa M
    Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
    [No Abstract]   [Full Text] [Related]  

  • 27. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
    Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
    J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method.
    Cross NA; Kellock DJ; Kinghorn GR; Taraktchoglou M; Bataki E; Oxley KM; Hawkey PM; Eley A
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2311-3. PubMed ID: 10471587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
    Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
    Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
    Korting HC; Hartinger A
    Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin.
    Kelkar MS; Saraf AP; Bakhle DS; Nazare V; Ajay S; Hegde S; Lal HM; Cooverji ND; Bruzzese T
    Int J Clin Pharmacol Res; 1998; 18(3):137-43. PubMed ID: 9825270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Chlamydia trachomatis to trovafloxacin.
    Jones RB; Van der Pol B; Johnson RB
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():63-5. PubMed ID: 9222072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials.
    Filardo S; Di Pietro M; Pasqualetti P; Manera M; Diaco F; Sessa R
    PLoS One; 2021; 16(5):e0251075. PubMed ID: 33974662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA.
    Sanchez CJ; Shiels SM; Tennent DJ; Hardy SK; Murray CK; Wenke JC
    Clin Orthop Relat Res; 2015 Sep; 473(9):2874-84. PubMed ID: 25896136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
    Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
    Lefèvre JC; Lépargneur JP
    Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.